Companies reporting AI use or trials
Includes internal use and customer products, under our broad generative-AI definition. Plans alone do not count.
See the company listWhat company reports say about generative AI, from trials and plans to systems in use.
Includes 91 Hong Kong-listed companies. Historical charts cover the companies with comparable figures.
Includes internal use and customer products, under our broad generative-AI definition. Plans alone do not count.
See the company listIncludes plans as well as systems already in use.
Reports · FY2022–Q3 2026 tracked filings. One company can contribute many statements. Hong Kong reports show selected excerpts, so statement totals do not rank AI use. How we count
Mindray (迈瑞医疗) supplies medical equipment and clinical software. Its FY2025 filing describes three separate systems: a hospital-used intensive-care model for clinical records, a county ultrasound quality-control project, and a multilingual medical-equipment technical-service assistant. The clinical users are hospital staff, not Mindray employees.
One example from the reports. It may not reflect the rest of the sector.
FY25 annual report · Operations · In use · Inside the company
过精密制造、配合全自动化装配及AI 视觉检测 系统,保证产品一致性与可靠性持续达到行业领先水平。
FY25 annual report · Customer service · In use · Inside the company
我们通过AI 驱动数智化服务平台升级,构建以客户为中心的数智化服 务管理体系。
FY25 annual report · Other / unspecified · In use · Inside the company
围术期大模型实现了术前计划、术中预警、术后守护的全流程赋 能
Company-reported figures, with links to the source passages. Some describe staffing, products or revenue rather than benefits from AI.
New Installations in 2025
“瑞影生态”已经覆盖了全国31 个省、市、自治区,实现累计装机超 20,100 套
In use · For customers · Open the source · View this statement
Average Time Saved per Level III Prenatal Screening Exam
该方案可有效提升检查效率,III 级产筛检查平均节省约10 分钟,单 个检查按键操作减少300 余次
In use · For customers · Open the source · View this statement
Initial Hospital Deployments
公司正式发布“启元检验大模型”,这是专为医学检验科室打造的AI 专家系统
In use · For customers · Open the source · View this statement
Reduction in Manual Entry
瑞智重症决策辅助系统&启元重症医学大模型:作为全球首个临床落地的重症医疗大模型
In use · For customers · Open the source · View this statement
Reduction in Assistant Workload
瑞影妇产超声数智系统&启元妇产大模型:深度融合人工智能与大数据技术
In use · For customers · Open the source · View this statement
Reduction in Physician Workload
瑞影妇产超声数智系统&启元妇产大模型:深度融合人工智能与大数据技术
In use · For customers · Open the source · View this statement
Company AI project passages by type of work, including plans. One company can appear many times; the latest year may be incomplete.
| Type of work | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Product design and risk assessment | 17 | 43 | 97 | 351 |
| Operations | 4 | 5 | 34 | 129 |
| Customer service | 6 | 15 | 54 | 74 |
| Software and IT | 1 | 5 | 19 | 112 |
| Other / unspecified | 7 | 17 | 46 | 42 |
| Office administration | 1 | 1 | 11 | 22 |
| Risk and compliance | 0 | 1 | 6 | 20 |
All 240 companies covered here. Statement counts include plans and repeat descriptions of the same project.
| Company | Stock code / ID | Market cap | Project passages | Reported figures |
|---|---|---|---|---|
| Mindray | 300760 | RMB217.4B | 226 | 0 |
| Aier Eye Hospital | 300015 | RMB82B | 103 | 0 |
| United Imaging Healthcare | 688271 | RMB96.7B | 80 | 0 |
| Jointown | 600998 | RMB25.7B | 73 | 0 |
| MGI | 688114 | RMB23B | 73 | 0 |
| Haier Biomedical | 688139 | RMB9.9B | 50 | 0 |
| Fosun Pharma | 600196 | RMB60.2B | 37 | 0 |
| Bloomage Biotech | 688363 | RMB16B | 36 | 0 |
| Livzon Pharmaceutical | 000513 | RMB28.1B | 31 | 0 |
| SonoScape | 300633 | RMB9.1B | 31 | 0 |
| Dashenlin | 603233 | RMB24.1B | 26 | 0 |
| Yunnan Baiyao | 000538 | RMB98.5B | 20 | 0 |
| Hengrui Pharma | 600276 | RMB319.1B | 20 | 0 |
| Huadong Medicine | 000963 | RMB45.4B | 19 | 0 |
| Tasly | 600535 | RMB20.9B | 19 | 0 |
| Sansure Biotech | 688289 | RMB8.6B | 18 | 0 |
| Changchun High-Tech | 000661 | RMB28.7B | 17 | 0 |
| Meihao Medical | 301363 | RMB13.4B | 16 | 0 |
| Health | 600380 | RMB19B | 16 | 0 |
| Kelun Pharmaceutical | 002422 | RMB67.9B | 15 | 0 |
| ACROBiosystems | 301080 | RMB14B | 15 | 0 |
| Chipscreen Biosciences | 688321 | RMB9B | 15 | 0 |
| Chuanning Biotechnology | 301301 | RMB17B | 11 | 0 |
| Asymchem | 002821 | RMB53.4B | 10 | 0 |
| Wantai Biological | 603392 | RMB28.9B | 10 | 0 |
| Autobio | 603658 | RMB21.9B | 10 | 0 |
| Shanghai RAAS | 002252 | RMB30.7B | 9 | 0 |
| Novoprotein | 688137 | RMB9.4B | 9 | 0 |
| Laobaixing | 603883 | RMB10.9B | 8 | 0 |
| Vazyme | 688105 | RMB10.9B | 8 | 0 |
| BeiGene | 688235 | RMB432.1B | 8 | 0 |
| Kangmei Pharmaceutical | 600518 | RMB17.8B | 7 | 0 |
| Shanghai Pharmaceuticals | 601607 | RMB59.8B | 7 | 0 |
| Enhua Pharmaceutical | 002262 | RMB22.9B | 6 | 0 |
| Qizheng Tibetan Medicine | 002287 | RMB10.6B | 6 | 0 |
| Hisun Pharmaceutical | 600267 | RMB15.2B | 6 | 0 |
| Darentang | 600329 | RMB30.5B | 6 | 0 |
| 3SBio | 688336 | RMB28.8B | 6 | 0 |
| 3D Medicines Inc. | 01244 | HK$0.7B | 5 | 0 |
| Viva Biotech Holdings | 01873 | HK$2.6B | 5 | 0 |
| Simcere Pharmaceutical Group Ltd. | 02096 | HK$26B | 5 | 0 |
| China Resources Pharmaceutical Group Ltd. | 03320 | HK$29.1B | 5 | 0 |
| Snibe | 300832 | RMB47.6B | 5 | 0 |
| Cofoe Medical | 301087 | RMB11.1B | 5 | 0 |
| Hualan | 301093 | RMB10.3B | 5 | 0 |
| Liaoning Chengda | 600739 | RMB14.7B | 5 | 0 |
| CR Jiangzhong | 600750 | RMB14.4B | 5 | 0 |
| Mabwell | 688062 | RMB9.1B | 5 | 0 |
| Chengda Biotech | 688739 | RMB8.5B | 5 | 0 |
| Haisco Pharmaceutical | 002653 | RMB66.2B | 4 | 0 |
| HBM Holdings Ltd. - B | 02142 | HK$8.5B | 4 | 0 |
| Keymed Biosciences Inc. - B | 02162 | HK$20B | 4 | 0 |
| Sirnaomics Ltd. - B | 02257 | HK$0.5B | 4 | 0 |
| AIM Vaccine Co., Ltd. | 06660 | HK$0.8B | 4 | 0 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 06990 | HK$75.1B | 4 | 0 |
| Walvax Biotechnology | 300142 | RMB17.2B | 4 | 0 |
| Gan & Lee | 603087 | RMB40.2B | 4 | 0 |
| Micro-Tech | 688029 | RMB15.9B | 4 | 0 |
| Zelgen | 688266 | RMB22.5B | 4 | 0 |
| iRay Technology | 688301 | RMB23.6B | 4 | 0 |
| MicroPort EP | 688351 | RMB8.3B | 4 | 0 |
| Sinopharm Uniform | 000028 | RMB12.7B | 3 | 0 |
| Puluo Pharmaceutical | 000739 | RMB22.6B | 3 | 0 |
| NHU | 002001 | RMB77.7B | 3 | 0 |
| Salubris | 002294 | RMB33.1B | 3 | 0 |
| CSPC Pharmaceutical Group Ltd. | 01093 | HK$90.6B | 3 | 0 |
| China Isotope & Radiation Corporation | 01763 | HK$0.9B | 3 | 0 |
| Everest Medicines Ltd. | 01952 | HK$9.6B | 3 | 0 |
| TYK Medicines, Inc - B | 02410 | HK$1.2B | 3 | 0 |
| Hua Medicine - B | 02552 | HK$2.3B | 3 | 0 |
| Shanghai Henlius Biotech, Inc. | 02696 | HK$17.1B | 3 | 0 |
| Chase Sun Pharmaceutical | 300026 | RMB9.1B | 3 | 0 |
| Oupucon | 300595 | RMB9.1B | 3 | 0 |
| Shandong Pharmaceutical Glass | 600529 | RMB11.9B | 3 | 0 |
| Junshi Biosciences | 688180 | RMB30.6B | 3 | 0 |
| HUTCHMED (China) Ltd. | 00013 | HK$18.1B | 2 | 0 |
| Sihuan Pharmaceutical Holdings Group Ltd. | 00460 | HK$6.6B | 2 | 0 |
| China Traditional Chinese Medicine Holdings Co. Ltd. | 00570 | HK$5.9B | 2 | 0 |
| China Medical System Holdings Ltd. | 00867 | HK$23.9B | 2 | 0 |
| Sino Biopharmaceutical Ltd. | 01177 | HK$90.1B | 2 | 0 |
| Ascletis Pharma Inc. - B | 01672 | HK$5.2B | 2 | 0 |
| Brii Biosciences Ltd. - B | 02137 | HK$0.7B | 2 | 0 |
| Jiangsu Recbio Technology Co., Ltd. - B | 02179 | HK$1.8B | 2 | 0 |
| Luye Pharma Group Ltd. | 02186 | HK$6.3B | 2 | 0 |
| WuXi Biologics (Cayman) Inc. | 02269 | HK$183.1B | 2 | 0 |
| VISEN Pharmaceuticals - B | 02561 | HK$1.6B | 2 | 0 |
| Xuanzhu Biopharmaceutical Co., Ltd. - B | 02575 | HK$4.5B | 2 | 0 |
| Guangzhou Innogen Pharmaceutical Group Co., Ltd. - B | 02591 | HK$1.4B | 2 | 0 |
| Fujian Haixi Pharmaceuticals Co., Ltd. | 02637 | HK$11B | 2 | 0 |
| Shanghai Bao Pharmaceuticals Co., Ltd. - B | 02659 | HK$1.2B | 2 | 0 |
| China Shineway Pharmaceutical Group Ltd. | 02877 | HK$6.2B | 2 | 0 |
| Sunshine Lake Pharma Co., Ltd. | 06887 | HK$12.7B | 2 | 0 |
| Shandong Boan Biotechnology Co., Ltd. | 06955 | HK$1.9B | 2 | 0 |
| Edding Genor Group Holdings Ltd. | 06998 | HK$3.2B | 2 | 0 |
| Duality Biotherapeutics, Inc. - B | 09606 | HK$9.5B | 2 | 0 |
| Akeso, Inc. | 09926 | HK$76.7B | 2 | 0 |
| Zuoli Pharmaceutical | 300181 | RMB8.5B | 2 | 0 |
| Hanyu Pharmaceutical | 300199 | RMB20.1B | 2 | 0 |
| Wolwo Bio-Pharmaceutical | 300357 | RMB11.4B | 2 | 0 |
| Porton Pharma Solutions | 300363 | RMB11.8B | 2 | 0 |
| Imeik | 300896 | RMB25.9B | 2 | 0 |
| China Pharma | 600056 | RMB12.7B | 2 | 0 |
| Baiyunshan Pharma | 600332 | RMB31.5B | 2 | 0 |
| Pien Tze Huang | 600436 | RMB78.7B | 2 | 0 |
| Conba | 600572 | RMB10.5B | 2 | 0 |
| Zhende Medical | 603301 | RMB22B | 2 | 0 |
| BrightGene | 688166 | RMB12.6B | 2 | 0 |
| Amoytop Biotech | 688278 | RMB17.4B | 2 | 0 |
| Sepax | 688758 | RMB9.4B | 2 | 0 |
| Wanze | 000534 | RMB8.4B | 1 | 0 |
| Yifan Pharmaceutical | 002019 | RMB10.8B | 1 | 0 |
| Zhongsheng Pharmaceutical | 002317 | RMB21.8B | 1 | 0 |
| Xianju Pharmaceutical | 002332 | RMB8.5B | 1 | 0 |
| 3SBio Inc. | 01530 | HK$34B | 1 | 0 |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B | 01541 | HK$1.2B | 1 | 0 |
| Fusen Pharmaceutical Co. Ltd. | 01652 | HK$0.8B | 1 | 0 |
| Consun Pharmaceutical Group Ltd. | 01681 | HK$12.8B | 1 | 0 |
| Lepu Biopharma Co., Ltd. | 02157 | HK$5.7B | 1 | 0 |
| CARsgen Therapeutics Holdings Ltd. - B | 02171 | HK$6.3B | 1 | 0 |
| Mabpharm Ltd. - B | 02181 | HK$1.8B | 1 | 0 |
| Clover Biopharmaceuticals, Ltd. - B | 02197 | HK$1.6B | 1 | 0 |
| Abbisko Cayman Ltd. - B | 02256 | HK$4.4B | 1 | 0 |
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. - B - H Sh | 02335 | HK$3.2B | 1 | 0 |
| PegBio Co., Ltd. - B | 02565 | HK$1.6B | 1 | 0 |
| GenFleet Therapeutics (Shanghai) Inc. - B | 02595 | HK$7.9B | 1 | 0 |
| Hansoh Pharmaceutical Group Co. Ltd. | 03692 | HK$196.2B | 1 | 0 |
| Zhongzhi Pharmaceutical Holdings Ltd. | 03737 | HK$0.5B | 1 | 0 |
| CPBIO Holding Co. Ltd. | 03839 | HK$1.9B | 1 | 0 |
| Suzhou Ribo Life Science Co., Ltd. - B | 06938 | HK$7.1B | 1 | 0 |
| Antengene Corporation Ltd. - B | 06996 | HK$1.9B | 1 | 0 |
| Metis TechBio Co., Ltd. - P | 07666 | HK$12.1B | 1 | 0 |
| Zai Lab Ltd. | 09688 | HK$21.7B | 1 | 0 |
| Jafron Biomedical | 300529 | RMB15.7B | 1 | 0 |
| Betta Pharmaceuticals | 300558 | RMB19B | 1 | 0 |
| Intco Medical | 300677 | RMB29.2B | 1 | 0 |
| Yipinhong | 300723 | RMB12.8B | 1 | 0 |
| Sino Biological | 301047 | RMB12.1B | 1 | 0 |
| Humanwell | 600079 | RMB32.4B | 1 | 0 |
| Lingrui Pharmaceutical | 600285 | RMB12.9B | 1 | 0 |
| Sinopharm Modern | 600420 | RMB10.7B | 1 | 0 |
| Sinopharm | 600511 | RMB21.4B | 1 | 0 |
| Jichuan Pharmaceutical | 600566 | RMB27.7B | 1 | 0 |
| Mayinglong | 600993 | RMB10.7B | 1 | 0 |
| CanSino | 688185 | RMB16.8B | 1 | 0 |
| Balance Medical | 688198 | RMB9.4B | 1 | 0 |
| OPM | 688293 | RMB9.2B | 1 | 0 |
| InnoCare | 688428 | RMB44.2B | 1 | 0 |
| Sino Biological | 688520 | RMB14B | 1 | 0 |
| Allist | 688578 | RMB36.7B | 1 | 0 |
| North Star Life | 688712 | RMB11.4B | 1 | 0 |
| ORYZON | 688765 | RMB13.1B | 1 | 0 |
| Pailin Bio | 000403 | RMB8.5B | 0 | 0 |
| Dong-E-E-Jiao | 000423 | RMB32.3B | 0 | 0 |
| Jilin Aodong | 000623 | RMB19.9B | 0 | 0 |
| Shandong Xinhua Pharmaceutical | 000756 | RMB8.5B | 0 | 0 |
| Tonghua Jinma | 000766 | RMB15.9B | 0 | 0 |
| CSPC Jingfeng | 000908 | RMB8.8B | 0 | 0 |
| Hualan Biological | 002007 | RMB21.5B | 0 | 0 |
| Jingxin Pharmaceutical | 002020 | RMB10B | 0 | 0 |
| Haixiang Pharmaceutical | 002099 | RMB9.1B | 0 | 0 |
| Guilin Sanjin | 002275 | RMB8.4B | 0 | 0 |
| Hepalink | 002399 | RMB13.4B | 0 | 0 |
| Yiling Pharmaceutical | 002603 | RMB25.7B | 0 | 0 |
| Dongcheng Pharmaceutical | 002675 | RMB10.5B | 0 | 0 |
| Aosaikang | 002755 | RMB11.3B | 0 | 0 |
| Kanghong Pharmaceutical | 002773 | RMB20.7B | 0 | 0 |
| Jacobio Pharmaceuticals Group Co., Ltd. - B | 01167 | HK$3.6B | 0 | 0 |
| CANbridge Pharmaceuticals Inc. - B | 01228 | HK$1.1B | 0 | 0 |
| Shanghai Pioneer Holding Ltd | 01345 | HK$2.5B | 0 | 0 |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. | 01349 | HK$0.8B | 0 | 0 |
| Ocumension Therapeutics - B | 01477 | HK$3.9B | 0 | 0 |
| LongBio Pharma (Suzhou) Co., Ltd. - B | 01779 | HK$3.8B | 0 | 0 |
| Innovent Biologics, Inc. | 01801 | HK$139.3B | 0 | 0 |
| SSY Group Ltd. | 02005 | HK$7.4B | 0 | 0 |
| Laekna, Inc. - B | 02105 | HK$2.5B | 0 | 0 |
| JW (Cayman) Therapeutics Co. Ltd - B | 02126 | HK$0.9B | 0 | 0 |
| WuXi XDC Cayman Inc. | 02268 | HK$84.7B | 0 | 0 |
| Dawnrays Pharmaceutical (Holdings) Ltd. | 02348 | HK$1.4B | 0 | 0 |
| Beijing Luzhu Biotechnology Co., Ltd. - B | 02480 | HK$3.1B | 0 | 0 |
| Wuhan YZY Biopharma Co., Ltd. - B | 02496 | HK$0.7B | 0 | 0 |
| Qyuns Therapeutics Co., Ltd. - B | 02509 | HK$3.4B | 0 | 0 |
| HighTide Therapeutics, Inc. - B | 02511 | HK$2.1B | 0 | 0 |
| Beijing Biostar Pharmaceuticals Co., Ltd. - B | 02563 | HK$1.3B | 0 | 0 |
| Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. | 02566 | HK$1.2B | 0 | 0 |
| CStone Pharmaceuticals - B | 02616 | HK$7.9B | 0 | 0 |
| TransThera Sciences (Nanjing), Inc. - B | 02617 | HK$2.6B | 0 | 0 |
| Vigonvita Life Sciences Co., Ltd. - B | 02630 | HK$12.6B | 0 | 0 |
| CF PharmTech, Inc. | 02652 | HK$1.7B | 0 | 0 |
| Sunho Biologics, Inc. - B | 02898 | HK$1B | 0 | 0 |
| Hanx Biopharmaceuticals (Wuhan) Co., Ltd. - B | 03378 | HK$3.8B | 0 | 0 |
| Medtide Inc. | 03880 | HK$2.7B | 0 | 0 |
| HJ Science Co., Ltd. - B | 06132 | HK$2B | 0 | 0 |
| Zhaoke Ophthalmology Ltd. - B | 06622 | HK$1.1B | 0 | 0 |
| Ascentage Pharma Group International | 06855 | HK$10.2B | 0 | 0 |
| TenNor Therapeutics (Suzhou) Ltd. - B | 06872 | HK$3.7B | 0 | 0 |
| Golden Throat Holdings Group Co. Ltd. | 06896 | HK$1.4B | 0 | 0 |
| IMPACT Therapeutics, Inc - B | 07630 | HK$2.4B | 0 | 0 |
| Jilin Province Huinan Changlong Bio-pharmacy Co. Ltd. | 08049 | HK$0.5B | 0 | 0 |
| Alebund Pharmaceuticals (Jiangsu) Ltd. - B | 09637 | HK$3.8B | 0 | 0 |
| Nanjing Leads Biolabs Co., Ltd. - B | 09887 | HK$7.1B | 0 | 0 |
| Kintor Pharmaceutical Ltd. - B | 09939 | HK$0.7B | 0 | 0 |
| Alphamab Oncology - B | 09966 | HK$6B | 0 | 0 |
| Lummy Pharmaceutical | 300006 | RMB12B | 0 | 0 |
| Anke Biology | 300009 | RMB12.8B | 0 | 0 |
| Zhifei Biological | 300122 | RMB33.2B | 0 | 0 |
| Shutaishen | 300204 | RMB9.2B | 0 | 0 |
| Changshan Pharmaceutical | 300255 | RMB17.2B | 0 | 0 |
| Guangshengtang | 300436 | RMB12.4B | 0 | 0 |
| Xingqi Eye Drops | 300573 | RMB11.9B | 0 | 0 |
| Kangtai Biological | 300601 | RMB13.2B | 0 | 0 |
| CSPC Innovation | 300765 | RMB48.3B | 0 | 0 |
| Baiyang Pharmaceutical | 301015 | RMB13.2B | 0 | 0 |
| Hualan Vaccine | 301207 | RMB8.8B | 0 | 0 |
| Tiankang | 301263 | RMB9.6B | 0 | 0 |
| 301569 | 301569 | — | 0 | 0 |
| CR Double-Crane | 600062 | RMB15.8B | 0 | 0 |
| Tongrentang | 600085 | RMB32.6B | 0 | 0 |
| Tiantan Biological | 600161 | RMB23.7B | 0 | 0 |
| Tibet Pharmaceutical | 600211 | RMB12.6B | 0 | 0 |
| Zhejiang Medicine | 600216 | RMB10.1B | 0 | 0 |
| Huahai Pharmaceutical | 600521 | RMB25.2B | 0 | 0 |
| Harbin Pharmaceutical | 600664 | RMB13B | 0 | 0 |
| Haixin | 600851 | RMB10.2B | 0 | 0 |
| Tonghua Dongbao | 600867 | RMB14.9B | 0 | 0 |
| Weigao Blood Purification | 603014 | RMB24.3B | 0 | 0 |
| Jianyou | 603707 | RMB13.7B | 0 | 0 |
| Buchang Pharmaceutical | 603858 | RMB15.4B | 0 | 0 |
| Yifeng Pharmacy | 603939 | RMB30.9B | 0 | 0 |
| Guobang Pharmaceutical | 605507 | RMB12.1B | 0 | 0 |
| MicroPort Endovascular | 688016 | RMB10.6B | 0 | 0 |
| Sinopep | 688076 | RMB8.7B | 0 | 0 |
| 688192 | 688192 | — | 0 | 0 |
| Olymvax | 688319 | RMB10.8B | 0 | 0 |
| RemeGen | 688331 | RMB54.1B | 0 | 0 |
| Zhixiang Jintai | 688443 | RMB9.3B | 0 | 0 |
| Baili Tianheng | 688506 | RMB103.2B | 0 | 0 |
| APT Medical | 688617 | RMB40.6B | 0 | 0 |
| Nanomicro | 688690 | RMB14.8B | 0 | 0 |
| 688806 | 688806 | — | 0 | 0 |
| 688837 | 688837 | — | 0 | 0 |
| Sector total | 1,338 | 0 | ||
Market caps use our listing snapshots and the currencies shown. Hong Kong values cover the Hong Kong listing only. A dash means no value was available; zero passages means we found no qualifying company project.
Figures are company-reported. Our definitions and checks are in the methodology.